← Leaderboards
Rita Elena Serda
University Of New Mexico
$1,380,245
Attributed
$1,380,245
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $840K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,380,245 · 3
By mechanism
R01$948,125 · 1
R21$356,469 · 1
F31$75,651 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellMediatingCellsImmunotherapyMalignant Neoplasm Of OvaryMouse ModelHla-A GeneImmuneClinical TranslationImmunogenicAgonistMalignant NeoplasmsAllelesAscitesImmune ActivationCell LineHuman BiologyHumanized MouseCancer CellAnti-CancerCancer ModelCancer PatientLeukocyte ActivationPreclinical Study
Grant awards (6)
TLR Agonist Nano-Immune Therapy for Peritoneal Metastases$464,569
R01 · FY2025 · CA · contact PI
TLR Agonist Nano-Immune Therapy for Peritoneal Metastases$483,556
R01 · FY2024 · CA · contact PI
Preclinical Efficacy of Allogeneic and Human Silicified Cancer Vaccines$356,469
R21 · FY2024 · CA · contact PI
Cytochrome P450C24 Regulation in Prostate Cancer$19,745
F31 · FY2006 · CA · contact PI
Cytochrome P450C24 Regulation in Prostate Cancer$28,148
F31 · FY2005 · CA
Cytochrome P450C24 Regulation in Prostate Cancer$27,758
F31 · FY2004 · CA